IL18 and leukemia: In a leukemia model, CD56dim NK cells activated by inflammatory cytokines IL-12, IL-15, and IL-18 will produce elevated levels of IFN-γ as part of a memory-like response when subsequently exposed to cancer cells, suggesting a possible anticancer role for this population [12].